The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

LY6E is an antiviral restriction factor that inhibits coronavirus spike-mediated fusion, but the
cell types in vivo that require LY6E for protection from respiratory coronavirus infection are …

Background Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with a high burden of
both pulmonary and extrapulmonary comorbidities. Research Question Do these …

Background: D-dimer, generated upon the degradation of fibrin, is extensively used to detect
thrombosis in various diseases. It is also explored as a marker for thrombosis in cases with …

According to the data from the World Health Organization, about 800 million of the world
population had contracted coronavirus infection caused by SARS-CoV-2 by mid-2023 …

The COVID-19 pandemic appeared in late 2019 and became a major health concern with
rapid transmission and very high mortality rates across the globe. Although precautionary …

COVID-19 is a systemic disease caused by the etiologic agent SARS-CoV-2, first reported in
Hubei Province in Wuhan, China, in late 2019. The SARS-CoV-2 virus has evolved over …

In this study, we analyzed the potential associations of selected laboratory and anamnestic
parameters, as well as 12 genetic polymorphisms (SNPs), with clinical COVID-19 …

Background: The Veterans Health Administration Office of Research and Development
(ORD) played a key role in the federal government's response to the COVID-19 pandemic …

The global viral pandemic of COVID-19, caused by SARS-CoV-2 created an unprecedented
demand for rapid diagnosis, containment, and treatment of the disease. However, the …